© Illustration: Risto Kurkinen
Alzheimer’s Association (alz.org) has a vision of “a world without Alzheimer’s”.
January 4, 2011, in Washington, Mr. President Obama wrote his name with his left hand on the National Alzheimer’s Project Act (NAPA), a Public Law 111-375 (S.3036), to “prevent or effectively treat Alzheimer’s disease by 2025.” [1-3]. NAPA also says “The Project shall expire December 31, 2025”, at the sunset, as it is called in the law [2].
December 11, 2013, in London, the world leaders of G8 (now G7) countries agreed on their “commitment to identify a cure or a disease- modifying therapy for dementia by 2025” [4].
George Vradenburg, chairman and co-founder of USAgainstAlzheimers.org (since 2010 with “the bold and attainable goal of ending Alzheimer’s by 2020”), got it right by saying, to the effect, that the first Alzheimer’s patient cured is in clinical trials.
1. National Alzheimer’s Project Act, S 3036, 111th Cong (2010). https://www.congress.gov/bill/111th-congress/senate-bill/3036
2. https://www.govtrack.us/congress/bills/111/s3036/text
3. Snyder HM, Hendrix J, Bain LJ, Carrillo MC (2015). Alzheimer’s disease research in the context of the national plan to address Alzheimer’s disease. Mol Aspects Med 43-44: 16-24.
4. https://www.alzheimers.org.uk/site/scripts/documents_info.php?documentID=2363&page-Number=4
Washington, D.C., July 30, 2024 — Today the Senate unanimously passed bipartisan legislation that will renew the nation’s commitment to addressing the Alzheimer’s crisis — the NAPA Reauthorization Act (S. 133 / H.R. 619) and the Alzheimer’s Accountability and Investment Act (S. 134 / H.R. 620).
https://www.alz.org/news/2024/senate-passes-napa-reauthorization-act